Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
264
Total Open
Publications
135
Total
Citations
12K
Open Access
Percentage
51%
Total
Publications
264
Total Open
Publications
135
Total
Citations
12K
Breakdown
Publisher Open
25%
Both
18%
Other Platform Open
7%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 35%
38
Hybrid 24%
27
No Guarantees 41%
45
Other Platform Open
Domain 78%
51
Institution 20%
13
Other Internet 15%
10
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 51 |
DOI | Other Internet | 8 |
Unknown Repository | Other Internet | 3 |
Yonsei University Medical Library - YUHSpace | Institution | 1 |
University of Zaragoza Repository - Zaguan | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
University of Melbourne - Minerva Access | Institution | 1 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 1 |
University of Cantabria - UCrea | Institution | 1 |
University of Bern - Bern Open Repository and Information System | Institution | 1 |